Outlook Therapeutics 8K filing
Outlook Therapeutics files 8K with SEC, disclosing other events and financial statements
Filed: 2026-05-26 AccNo: 0001104659-26-065992 Size: 236 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Outlook Therapeutics files 8K with SEC, disclosing other events and financial statements
Filed: 2026-05-26 AccNo: 0001104659-26-065992 Size: 236 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits